Log in

Relevant bibliographies by topics / Patient died

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Patient died'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Patient died.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Patient died"

1

Brittain, Chaka. "‘My patient died’." Nursing 49, no. 4 (2019): 50–51. http://dx.doi.org/10.1097/01.nurse.0000553276.26343.5f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Heise, Barbara A., Debra K. Wing, and Amy H. R. Hullinger. "My Patient Died." Nursing Education Perspectives 39, no. 6 (2018): 355–59. http://dx.doi.org/10.1097/01.nep.0000000000000335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Stewart, Bonnie P. "My Patient Died Today." AJN, American Journal of Nursing 94, no. 6 (1994): 80. http://dx.doi.org/10.1097/00000446-199406000-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Barrett, Allison M. "When my patient died." BMJ 335, Suppl S6 (2007): 0712444. http://dx.doi.org/10.1136/sbmj.0712444.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Smith, Joshua. "A Patient Just Died." Journal of Palliative Medicine 19, no. 1 (2016): 116. http://dx.doi.org/10.1089/jpm.2015.0282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Fortson, Darryl L. "My first patient died." Postgraduate Medicine 88, no. 1 (1990): 35–36. http://dx.doi.org/10.1080/00325481.1990.11716355.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sokol, D. K. ""The patient would have died anyway"." BMJ 346, jan15 1 (2013): f285. http://dx.doi.org/10.1136/bmj.f285.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Aral, Mustafa M. "Surgery Was Successful but the Patient Died." Journal of Hydrologic Engineering 16, no. 2 (2011): 91–92. http://dx.doi.org/10.1061/(asce)he.1943-5584.0000313.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Turck, Marvin. "An AIDS Patient Who Died Too Soon." Hospital Practice 20, no. 1 (1985): 77–80. http://dx.doi.org/10.1080/21548331.1985.11702971.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Brescia, Frank J., Matthew Sadof, and Janice Barstow. "Retrospective Analysis of a Home Care Hospice Program." OMEGA - Journal of Death and Dying 15, no. 1 (1985): 37–44. http://dx.doi.org/10.2190/ye36-xgym-2hw7-bebq.

Full text

Abstract:

This is a retrospective study of patients who died in the Overlook Hospice Home Care Program during a six-month period. Parameters to define and document quality palliative care were measured and differences between the patient population who died at home and those who died in the hospital setting were also recorded. Among the patients who died at home, there was no symptom complex which was perceived as unmanageable by the patient's family, nurse, or physician. We could not predict which patients would be able to die at home in this study. In the future, more complete documentation of patient status, specific symptoms, and whether these symptoms are relieved will be necessary.

APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Patient died"

1

Saunders, Kelly D. M. "The experiences of pediatric nurses after a patient has died." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp04/mq24908.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Casper-Futterman, Evan. "The Operation was Successful but the Patient Died: The Politics of Crisis and Homelessness in Post-Katrina New Orleans." ScholarWorks@UNO, 2011. http://scholarworks.uno.edu/td/1368.

Full text

Abstract:

On July 4th, 2007, a small group of housing activists set up a tent city encampment in a plaza adjacent to New Orleans City Hall. The action resulted in the creation of Homeless Pride, a small group of politicized Plaza residents. Six months later, hundreds of homeless people were moved from the park, and it was fenced off. Using archival videos, interviews, and news media, this thesis analyzes the opportunities and constraints that activists, service providers, and local officials faced in light of two intersecting and overlapping contexts. The first context is the immediate crisis of the levee failures after Hurricane Katrina, and the second is the longer-term national political-economic context of “neoliberal urbanism”. Because of dire short-term circumstances, Homeless Pride articulated a message of homelessness as a “crisis” even though they had larger structural goals and vision. In light of recent “Occupy” movements, this case study addresses crucial questions for organizers and policymakers attempting to combat poverty and wealth inequality.

APA, Harvard, Vancouver, ISO, and other styles

3

Shinaberger, Christian S. "Hemodialysis patients-relationships with dietary protein and vitamin D dosage and impact on patient survival." Diss., Restricted to subscribing institutions, 2008. http://proquest.umi.com/pqdweb?did=1666908801&sid=1&Fmt=2&clientId=1564&RQT=309&VName=PQD.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Nilsson, Christina. "Kvinnors upplevelse av preoperativ information samt livskvalitet kring bröstrekonstruktion med DIEP operation." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2014. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-226862.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Walts, Lynn Maddox Walker George M. "Patient classification system : an integrated method for measuring nursing intensity and optimizing resource allocation /." See options below, 1992. http://proquest.umi.com/pqdweb?did=745208811&sid=2&Fmt=2&clientId=68716&RQT=309&VName=PQD.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Dietel, Moritz Benjamin. "Die Weiterverwendung von behandlungsbedingt gewonnenem Gewebematerial /." Aachen : Shaker, 2006. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=015404277&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Athar, Nelofar. "Development of indigenous enteral formulae /." View thesis View thesis, 1995. http://library.uws.edu.au/adt-NUWS/public/adt-NUWS20030521.092507/index.html.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Harris, Elizabeth Dorothy. "Assessment of factors which influence compliance to diet revision therapy for food allergy in a pediatric population." Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26834.

Full text

Abstract:

Failure to comply with prescribed regimens is a major reason for the failure of treatment programs. This study investigated factors which are related to compliance with prescribed diet revision therapy for food allergies in school-aged children. Forty-five children, aged 6 to 12 years, who were under a physician's care for food allergies, formed the sample. The Health Belief Model was used as the basis for a questionnaire devised to measure these factors. The development of the Diet Revision Therapy Parent Questionnaire involved a pilot test and revisions; the resulting instrument consists of 38 items organized into 4 subtests, of which one 7-item subtest is to be considered optional. The 38-item DRTPQ has a full scale internal consistency reliability of .87, and a composite reliability of .61 for the four subscales. The canonical correlation between 3 types of subjective ratings of compliance and the 4 subtests is .80, with 64% shared variance between these sets of variables. A discriminant function of 3 subtests of the DRTPQ proved capable of discriminating diet therapy dropouts from continuing subjects with 88.9% accuracy. These three subtests measured: 1. Parent and family life factors, such as the amount of perceived interference in normal routines, 2. Child's attitudes to the treatment and his/her normal behavior with respect to cooperation with parental demands, and 3. Belief in the benefits to be derived from the treatment. A fourth category of items measured perceived severity of the condition and perceived susceptibility to illness but proved not to predict compliance in this sample, although it may be useful in clinical practice. Suggestions for interventions to aid compliance are outlined.<br>Education, Faculty of<br>Educational and Counselling Psychology, and Special Education (ECPS), Department of<br>Graduate

APA, Harvard, Vancouver, ISO, and other styles

9

Caspero, Alexandra M. "Usual dietary intake among chronic fatigue syndrome patients." Scholarly Commons, 2009. https://scholarlycommons.pacific.edu/uop_etds/729.

Full text

Abstract:

The relationship between dietary intake and the pathology of CFS has been an area of intense speculation without strong research support. There may be important links between diet and symptoms such that dietary interventions may be efficacious as adjunct therapy. This study was designed to assess any dietary abnormalities among Chronic Fatigue Syndrome patients. The purpose of this study is to make a controlled assessment of usual dietary intake so that dietary recommendations for CFS patients can be made. A Diet History Questionnaire, provided by the National Institute of Health, was used to analyze usual dietary intake among CFS patients. Women, ages I 8 and older, diagnosed by a physician with CFS, and were asked to complete the online survey. To complete the questionnaire, participants were provided with a user name and password and asked to answer a number of questions about their dietary habit. Twenty (n=20) women with CFS completed the questionnaire. The results were compiled and analyzed using Diet-Calc software and compared with nonnative data. Several nutrients were found to be deficient in more than 75% of the CFS patients.

APA, Harvard, Vancouver, ISO, and other styles

10

Panagopoulou-Koutnatzi, Fereniki. "Die Selbstbestimmung des Patienten : eine Untersuchung aus verfassungsrechtlicher Sicht /." Berlin : Duncker & Humblot, 2009. http://opac.nebis.ch/cgi-bin/showAbstract.pl?u20=9783428129416.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Patient died"

1

Cooper, H. BSc (Hons), MSc, RGN, ed. Caring to the end?: A review of the care of patients who died in hospital within four days of admission. NCEPOD, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

The renal patient's guide to good eating: A cookbook for patients by a patient. C.C. Thomas, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Allbright, Anne. Diet and the cancer patient. BACUP, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Allbright, Anne. Diet and the cancer patient. BACUP, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

BACUP. Diet and the cancer patient. Bacup, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Binggeli, Frances B. Heart patient recipes. Vantage Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sjogren, Steve. The day I died. Regal Books, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sjogren, Steve. The day I died. Regal Books, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hill, Novella S. Diet for patients with renal disease. Dept. of the Air Force, Headquarters US Air Force, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Chhajer, Bimal. 201 diet tips for heart patients. Fusion Books, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Patient died"

1

Leape, Lucian L. "Partners in Progress: Patient Safety in the UK." In Making Healthcare Safe. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-71123-8_13.

Full text

Abstract:

AbstractIn 1997, Britons were shocked by a report from the General Medical Council (GMC) of a series of deaths from bungled surgery at the Bristol Royal Infirmary. In response to parents’ complaints, the GMC had launched an investigation into the high mortality of cardiac surgery of children at the Infirmary. It found that of 53 children who were operated on, 29 had died and 4 suffered severe brain damage. Three surgeons were found guilty of serious professional misconduct, and two were stricken from the medical register [1].

APA, Harvard, Vancouver, ISO, and other styles

2

Mahmoud, Omar. "The Operation was Successful but the Patient Died: Why Research on Innovation is Successful yet Innovations Fail." In Market Research Best Practice. John Wiley & Sons, Inc., 2015. http://dx.doi.org/10.1002/9781119208815.ch6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ringler, M. "Die „alte Frau“Die Frau im fortgeschrittenen Alter." In Patient Frau. Springer Vienna, 2001. http://dx.doi.org/10.1007/978-3-7091-6753-3_13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Springer-Kremser, M. "Das Klimakterium/Die Menopause Die sich selbst erfüllenden Prophezeiungen und die Wirklichkeit der Frauen." In Patient Frau. Springer Vienna, 2001. http://dx.doi.org/10.1007/978-3-7091-6753-3_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Korff, Ulrich. "Wo die Defizite entstehen." In Patient Krankenhaus. Gabler Verlag, 2012. http://dx.doi.org/10.1007/978-3-8349-7189-0_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Korff, Ulrich. "Wie die Defizite beseitigt werden." In Patient Krankenhaus. Gabler Verlag, 2012. http://dx.doi.org/10.1007/978-3-8349-7189-0_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kemeter, P. "Die Endokrinologie der geschlechtsreifen Frau." In Patient Frau. Springer Vienna, 2001. http://dx.doi.org/10.1007/978-3-7091-6753-3_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Korff, Ulrich. "Mit neuen Angeboten die eigene Wertschöpfung verlängern." In Patient Krankenhaus. Gabler Verlag, 2012. http://dx.doi.org/10.1007/978-3-8349-7189-0_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Knöbber, Dirk Ferdinand. "Die Pflege des Tracheostomas." In Der tracheotomierte Patient. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76337-3_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Freudenthaler, Ingeborg. "Die Verantwortung der Leitung." In Der zufriedene Patient. Springer Berlin Heidelberg, 2002. http://dx.doi.org/10.1007/978-3-642-55952-5_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Patient died"

1

Julian, D. G., L. S. Borthwick, D. Reid, et al. "APSAC versus placebo: A Multicenter Study of Safty and Early Morality in Acute Myocardial Infarction." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643619.

Full text

Abstract:

A prelimiry study was carried out of obtain data on mortality,benefit and the safety of anisoylated plasminogen streptokinase activator complec (APSAC).90 patients from 7 centers,with symptons of acute myocardial infarction of not more than 4 hours duration,were randomised to receiveeithere 30U of APSAC as an intravenous injection over 4 to 5 minutes or placebo given by the same route.45 patients recevied APSAC and placedo,mean time to treatment was 3 hours 20 minutes and 3 hours, respectively.Mortality at 30 days was 7 deaths in theplacebo group and 1 death in the APSAC group (p=0.058),these were all related either directly or indirectly to the infarct:cardiogenic shock (2),ventricular asystole(2) further acute myocardial infraction(2),ventricular fibrillation (1) and pulmonry embolism (1).The patient who died after APSAC therany had presented with an anterior infraction; 5 patients who died inthe placebo group presented with anterior infarcts and 2 with inferior infarcts. Most daeths occured in the group randomised 2 hours 30 minutes to 4 hours post-infarcation.Both systolic and diastolic blood pressure were generally similar in each groupfrom 1 hour to 1 month after treatment. 35 percent of petients in the placebo group experienced cardiovasular events (2 of whom died from cardiogenic shock) compared with 20 percent of APSAC of treated patients (1 of whom died from pulmonary embolism).Minor haematuria was apparent in a grater number of patients in the APSAC group after 12 hours, but there was no differnce between groups after 1 or 2 weeks.The result of this study ,although encouraging,should be interpreted with caution,mainly due to the small numbers of patients enrolled.There was however a trend towards incresed survival in the APSAC treated group (97.8 per cent) compared with84.4 cent survival in the placenbo groupat 30 days post-infarction.

APA, Harvard, Vancouver, ISO, and other styles

2

Heyermans, H. H. S., M. V. Huisman, H. R. Büller, J. V. D. Laan, and J. W. ten Cate. "SAFETY AND EFFICACY OF SERIAL IMPEDANCE PLETHYSMOGRAPHY IN THE DIAGNOSIS OF DEEP VEIN THROMBOSIS IN AN URBAN HOSPITAL: AN EXTERNAL VALIDATION STUDY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644199.

Full text

Abstract:

The clinical diagnosis of deep vein thrombosis (DVT) is unreliable. Impedance plethysmography (IPG) has become accepted as a highly reliable non-invasive method for DVT detection in symptomatic patients.It has a high sensitivity (95%) and specificity (96%) for proximal vein thrombosis. Studies with impedance plethysmography have however always been carried out in academic hospitals. To evaluate the safety and efficacy of serial impedance plethysmography alone in an urban hospital setting, a prospective study was done in an urban hospital, involving 234 consecutive outpatients with clinically suspected venous thrombosis. IPG was performed on days 1, 2 and 7. If all tesis remained normal the patient was not treated with oral anticoagulants. All patients were followed for 3 months. In 131 of the 234 patients (56%) IPG was repeatedly normal. Of these 131 patients, no patient died from venous thromboembolism during 3 months follow-up, completed in all patients, and no patient returned with signs of pulmonary embolism. One patient (0.8%) returned with objectively documented DVT after two months. In 103 of the 234 patients (44%) the IPG was abnormal. Venography confirmed the diagnosis of deep venous thrombosis in 92%.It is concluded that serial IPG is a safe and effective method to detect DVT in clinically suspected outpatients, referred to an urban hospital.

APA, Harvard, Vancouver, ISO, and other styles

3

Kruit, W. H. J., A. K. Sing, G. J. H. den Ottolander, A. C. de Beor, and J. J. C. Jonker. "VENOGRAPHY (VG) OF THE LOWER LIMBS IN THE MANAGEMENT OF PATIENTS WITH SUSPECTED PULMONARY EMBOLISM (PE)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644197.

Full text

Abstract:

In a prospective cohort study, we evaluated X-ray VG in the management of non-surgical patients with clinically suspected PE. Thusfar follow up is available on 131 consecutive patients with suspected PE. In all patients a perfusion lungscan (PS) was carried out within 24 hours. In case of a normal PS (group A, n=32), no anticoagulant (AC) therapy was given. In case of an abnormal PS, AC therapy was started (heparin) and a bilateral ascending VG was carried out within 72 hours. In 46 patients (group C) venous thrombosis (DVT) was demonstrated by VG, and these patients were treated with AC for 6 months. In 53 patients with suspected PE and an abnormal lungscan, bilateral VG did not show DVT (group B). AC therapy was discontinued in these patients These patients were then screened for 14 days with fibrinogen legscanning and impedance plethysmography (IPG), followed by IPG alone every 2 months for at least 1 year. In group B, 6 patients died in the follow up period. None of the patients had signs of PE at autopsy. One additional patient in group B developed DVT documented by repeat VG, 6 months after entry into the trial. According to these preliminary data, it seems safe to base the decision whether or not to treat a patient with suspected PE with AC, on the presence or absence of DVT in the lower limbs as demonstrated by VG

APA, Harvard, Vancouver, ISO, and other styles

4

Sadakata, H., H. Iri, T. Uchiyama, et al. "PROSPECTIVE STUDY ON DOSE SCHEDULE OF HEPARIN THERAPY FOR DIC COMPLICATION IN LEUKEMIA PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644195.

Full text

Abstract:

From the retrospective analysis of correlation between the activity of tissue factor (TFA) of leukemia cells (LC) and DIC complication in patients with acute leukemia, we have already reported an adequate dose schedule of heparin treatment for DIC can be calculated in accordance with the TFA of LC To evaluate this dose schedule, the prospective analysis was designed. Prior to the remission induction chemotherapy, TFA of LC obtained from 67 patients with leukemia (ANLL: M1;5, M2;22, M;34, M4;8, M5;4, M6;3, CML-BC: 11) was measured by Nemerson's two-stage method reported previously. Regardless of DIC complication, continuous heaprin therapy with 0, 15,000 or 9,700X + 9,000 units/day (X: logarithm value of TFA) was started with chemotherapy in patinet with 0, 0.8−4.1 U or >4.1 U of TFA, respectively. The complete remission and significant decrease of LC were achieved in 16 patients with ANLL and 5 patients with CML-BC, respectively. In 20 patients whose LC had 0.8 U of TFA or more (group A), 15 and 1 patients were complicated by DIC before and after start of the chmotherapy, respectively. DIC was improved in all of these patients. Other 4 patients were not complicated by DIC. There was no major bleeding due to heparin administration. In 47 patients whose LC had less than 0.8 U of TFA (group B), 40 patients were not complicated by DIC throughout the observation period. Remaining 4 and 3 patients were complicated by DIC before and after start of the chemotherapy, respectively. Among these patients, only one, whose DIC was due primarily to endotoxinemia, failed in control of the DIC. Consequently, in 67 patients subjected to this study, only one patient died of complicated DIC, although 17 patients (group A:4, group B:13) died of various causes other than DIC during the observation periods. These results suggest that our dose schedule of heparin is appropriate for both prevention and treatment of DIC complication in leukemia patients.

APA, Harvard, Vancouver, ISO, and other styles

5

Kakkar, S., E. Melissari, and V. V. Kakkar. "CONGENITAL SEVERE PROTEIN C DEFICIENCY IN ADULTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644304.

Full text

Abstract:

We (Melissari et al, 1985, T.R. 29 [1985] 641) were the first to identify the occurrence of severe protein C deficiency in an adult with thrombophilia and undetectable protein C levels. This report documents our clinical and laboratory resuts of this patient and his family, as well as another 8 patients, in two more, unrelated families. In these unique families with members suffering from severe protein C deficiency (≤6%), no one had experienced neonatal purpura fulminans. Symptoms started mainly in their early twenties, except in 2 patients who first had symptoms at the ages of 11 and 13. The expression of the protein C deficiency was mainly recurrent superficial and deep iliofemoral vein thrombosis and pulmonary embolism. The protein C deficiency was also expressed as generalised peritonitis due to massive messenteric vein thrombosis, cavernus sinus, renal vein thrombosis and priapism. In one of these families, five members died of intra-abdominal thrombosis before the age of 40. A compensated diffuse intra- vascular coagulation syndrome was observed during massive thromboembolic attacks as evidenced by high levels of D-Dimer (≥5000ng/ml). The treatment of choice was heparin or urokinase (with the exception of one patient), followed by heparin and fresh frozen plasma. Long term prophylaxis was LMW heparin or low dose warfarin plus stromba. The one patient who did not respond to the thrombolytic treatment with urokinase was found to have in his plasma a high titre of inhibitor against urokinase and prourokinase. This patient responded to streptokinase treatment. D-Dimer levels in these patients in non-crisis state were raised and proportional to the degree of the protein C deficiency.

APA, Harvard, Vancouver, ISO, and other styles

6

Bork, K., and G. Witzke. "LCNG-TEFM SUBSTITUTION WITH Cl-INACTIVATOR IN PATIENTS WITH HEREDITARY AND ACQUIRED Cl-INH DEFICIENCY AND LIFE-THREATENING ANGIOEDEMA." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644329.

Full text

Abstract:

Patients with hereditary car acquired cl-inactivator (Cl-INH) deficiency suffer frcm repeated episodes of oedema of the skin and internal organs, which often constitute a threat to life (laryngeal, pulmonary and brain oedama). The treatment which is rapidly effective in the other, much more common, forms of angio-oedema (idiopathic, allergic or anaphylactoid, often associated with urticaria) has little or no effect in these cases. This applies particularly to treatment with antihistamin agents and corticosteroids. However, in patients with hereditary angiooedana (HAE) Danazol is effective for long-term prophylaxis and the substitution of Cl-INH for acute treatment. In isolated cases long-term prophylaxis, which is generally reliable, cannot be used because of intolerability reactions. Moreover, it is ineffective in the oedema of acquired Cl-INH deficiency.As other forms of therapy did not achieve the desired response, long-term substitution with a concentrate of Cl-inactivator (Behringwerke AG, Marburg) was carried out in 2 patients (H.W., 47 yrs, male, hereditary angiooedana, 9 siblings died from angiooedana; W.K., 55 yrs, male, professional truipeter, suffering from angiooedana of unknown origin for 5 years, without other underlying disorders). The initial values wereSubstitution was carried out according to the clinical symptoms. Patient H.W. required 500 U Cl-inactivator every 4th day and patient W.K. 1000-1500 U every 5th day until. During substitution therapy (which in pat. H.W. has so far been carried out for 8 months and in pat. W.K. for 6 months) there was a rise in Cl-INH and C4 with an almost total absence of clinical syirptans. No undesirable effects were observed.

APA, Harvard, Vancouver, ISO, and other styles

7

Gerhart, T., H. Yett, A. Donovan, M. A. Lee, M. Smith, and E. W. Salzman. "ORGANON 10172 VS. WARFARINTO PREVENT VENOUS THROMBOSIS AFTER HIP FRACTURE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643686.

Full text

Abstract:

Deep venous thrombosis (DVT) remains a serious and frequent complication after fracture of the hip, and even the mostefficacious prophylactic agents, e.g., warfarin, may fail to prevent DVT in up to 2056 of cases. There is evidence that low molecular weight heparin or heparin-like agents may have advantages in antithrombotic prophylaxis with reduced hemorrhagic sideeffects in patients at risk of DVT. We are engaged in a randomized prospective trial comparing the antithrombotic effect ofwarfarin (PT 1.5x control)with that of Organon 10172, a mixture ofsulfated low molecular weight glycosamioglycans (750 anti-Xa u b.i.d. sc., begunpreop and continued 9 days, followe by warfarin). Diagnosis is by 125-1 fibrinogen scan and impedence plethysmography with confirmatory phlebography. At present71 patients have been admitted, and patient groups are comparable in age, sex, type of fracture, and all other significant respects. DVT has been diagnosed in 7of 36 patients given warfarin an in 1 of35 patients who received Organon10172. Pulmonary embolism has not beenencountered. GI bleeding has occurred twice on warfarin and once on Organon 10172 There has been no difference in estimated operative blood loss, transfusion requirements, or other major bleeding complications.One patient on warfarin died ofmyocardial infarction and pneumonia. There were no other adverse reactions.The study is still in progress. The present trend in the results suggests that the heparinoid Organon 10172 may be a promising new agent to prevent DVT in high risk patients, such as those with fractures of the hip.

APA, Harvard, Vancouver, ISO, and other styles

8

Jain, Vandana, Rupinder Sekhon, Shveta Giri, and Sudhir Rawal. "Role of radical surgery in early stages of vaginal cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685350.

Full text

Abstract:

Objectives: The objective of our present study was to evaluate the efficacy of radical vaginectomy with or without radical hysterectomy in patients with FIGO stage I and II vaginal cancers. Materials and Methods: A retrospective study was carried out on 13 patients aged 35 – 78 years. All the patients underwent radical surgery for vaginal cancer from April 2010 till June 2015. Kaplan- meier analyses was used to calculate the disease free survival and overall survival at 12 months. Results: The mean age of patients was 54.9 years. Twelve patients were with FIGO stage I while one had stage II vaginal cancer. The histopathology was squamous cell cancer in 9 patients, small cell neuroendocrine cancer in two patients and malignant melanoma in 2 patients. The lesion was confined to upper 2/3 of vagina in 8 cases and lower 1/3 was involved in 5 cases. All the patients underwent radical surgery. Lymph node dissection was done in eleven patients out of whom lymph nodes were positive in 4 patients. Three patients had positive margins. Adjuvant treatment was given to patients with positive margins or positive nodes. Six patients did not require any adjuvant treatment and two patients defaulted adjuvant treatment. One patient developed Vesico-vaginal fistula. Over a follow up period ranging from 6 to 67 months, recurrence developed in two patients and one of them died of disease. The 12 months Disease free survival was 82.1% and 12 months Overall Survival was 90.9%. Conclusion: Stage I and selected stage II vaginal cancer patients have good outcomes in terms of survival and local tumor control if managed judiciously by initial surgery followed by selective adjuvant therapy.

APA, Harvard, Vancouver, ISO, and other styles

9

Semenov, Sergey, Alexandr Bozhchenko, and Pavel Tolkach. "Iatrogenic death of a patient as a result of local anesthesia with the use of the drug “Naropin”." In Issues of determining the severity of harm caused to human health as a result of the impact of a biological factor. Publishing Center RIOR, 2020. http://dx.doi.org/10.29039/conferencearticle_5fdcb03ab42468.53224529.

Full text

Abstract:

The article considers the clinical and forensic aspects of the possibility of establishing a causal relationship between the use of the drug “Naropin” and the death of a patient during local anesthesia. In this case, the patient sought outpatient medical care for paraproctitis. The decision made by the doctor the decision for local anesthesia is the use of the drug “Naropin”. At 20 minutes of administration of the drug in the required dosage, the patient suddenly developed convulsions and clinical death occurred, and later the patient died. When conducting a forensic examination of the corpse, the most significant was the following: a small pinpoint wound in the upper quadrant of the right buttock, pulmonary edema, liquid blood and small loose blood clots in the heart cavities, brain edema. During a post-mortem Toxicological examination of the blood, the presence of ropivacaine (a component of naropine) was found to exceed the threshold toxic concentration. Repeated expert research has found that led to the onset of death-the erroneous introduction of the anesthetic “Naropin” directly into the blood vessel, which is prohibited by the instructions for its use due to a very narrow zone of toxic action.

APA, Harvard, Vancouver, ISO, and other styles

10

R., Senthil J., Santa A., Pavan KB, et al. "An Analysis of Acute Adverse Drug Reactions Occurring in Day Care Chemotherapy Setting in a Tertiary Care Cancer Centre." In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735376.

Full text

Abstract:

Abstract Introduction Acute adverse drug reactions (ADRs) in day care chemotherapy are not uncommon and easily manageable many a time. However, sometimes they may lead to untoward events. It is of paramount importance to document and analyze such events in contemporary medical oncology practice for the best utilization and planning of available personnel and resources. Objectives This study was aimed to analyze the acute ADRs occurring in day care cancer chemotherapy setting. Materials and Methods All acute ADRs reported in day care cancer chemotherapy setting, during the administration of chemotherapy, at Basavatarakam Indo American Cancer Hospital, Hyderabad, Telangana, India, were included in the study from June 15, 2020 to September 30, 2020. The ADRs were classified in to anaphylactic, allergic, and gastrointestinal (nausea/vomiting/heart burns/chest tightness). All ADRs were graded according to CTCAE version 5.0. Suspected drugs, time to reaction, and corrective measures were analyzed. Results During the study period, a total of 8,600 sessions of day care chemotherapy were administered. ADRs were noticed in 83 cases (~1%). Among the reported ADRs, anaphylactic reactions were noted in 20 patients (24%); allergic reactions of grades 1 and 2 were noted in 41 patients (49%). Gastrointestinal ADRs were noted in 30 patients (36%). Adverse reactions are mostly seen in oxaliplatin (22.8%), rituximab (14.4%), paclitaxel (15.6%), carboplatin (13.2%), and docetaxel (7.2%). In grade-I (10%) and grade-II (63%) resections, supportive treatment was provided and chemotherapy was continued. Grade-III ADRs were noted in 21 patients (25%) out of whom, 3 patients required short-term intensive care, chemotherapy was withheld until the next cycle in one patient, and chemotherapy regimen was changed in 3 patients. No patient died of ADR. Conclusion Serious ADRs are rare in contemporary medical oncology practice during day care chemotherapy administration. Most acute ADRs were easily managed.

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Patient died"

1

Chaparadza, Diana. An Analysis of Patient-Generated Health Data in Assisting Nurses and Physicians to Better Treat Patients with Hypertension. University of Tennessee Health Science Center, 2020. http://dx.doi.org/10.21007/chp.hiim.0080.

Full text

Abstract:

Patient Generated Health Data (PGHD is not new but it has gained more attention these past years due to the advent of smart devices, remote monitoring devices and many applications on various smart devices. PGHD reflects medications and treatment, lifestyle choices, and health history. Unlike traditional medical visits, where clinicians collect and manage data within their offices, PGHD is collected by patients throughout the course of their day and provides an insight of how they are responding to treatments or lifestyle choices. Examples include blood glucose monitoring or blood pressure readings using home health equipment, exercise and diet tracking using mobile applications or wearable devices such as the Fitbit or other smart watches.

APA, Harvard, Vancouver, ISO, and other styles

2

Bentley, Brooke, Marla J. De Jong, Debra K. Moser, and Ann R. Peden. Factors Related to Nonadherence of a Low Sodium Diet in Heart Failure Patients. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada419967.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Colonetti, Tamy, Micheli Mariot, Laura Colonetti, and Marina Costa. Effects of gluten free diet in patients with diabetes mellitus type1: systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dy, Sydney M., Arjun Gupta, Julie M. Waldfogel, et al. Interventions for Breathlessness in Patients With Advanced Cancer. Agency for Healthcare Research and Quality (AHRQ), 2020. http://dx.doi.org/10.23970/ahrqepccer232.

Full text

Abstract:

Objectives. To assess benefits and harms of nonpharmacological and pharmacological interventions for breathlessness in adults with advanced cancer. Data sources. We searched PubMed®, Embase®, CINAHL®, ISI Web of Science, and the Cochrane Central Register of Controlled Trials through early May 2020. Review methods. We included randomized controlled trials (RCTs) and observational studies with a comparison group evaluating benefits and/or harms, and cohort studies reporting harms. Two reviewers independently screened search results, serially abstracted data, assessed risk of bias, and graded strength of evidence (SOE) for key outcomes: breathlessness, anxiety, health-related quality of life, and exercise capacity. We performed meta-analyses when possible and calculated standardized mean differences (SMDs). Results. We included 48 RCTs and 2 retrospective cohort studies (4,029 patients). The most commonly reported cancer types were lung cancer and mesothelioma. The baseline level of breathlessness varied in severity. Several nonpharmacological interventions were effective for breathlessness, including fans (SMD -2.09 [95% confidence interval (CI) -3.81 to -0.37]) (SOE: moderate), bilevel ventilation (estimated slope difference -0.58 [95% CI -0.92 to -0.23]), acupressure/reflexology, and multicomponent nonpharmacological interventions (behavioral/psychoeducational combined with activity/rehabilitation and integrative medicine). For pharmacological interventions, opioids were not more effective than placebo (SOE: moderate) for improving breathlessness (SMD -0.14 [95% CI -0.47 to 0.18]) or exercise capacity (SOE: moderate); most studies were of exertional breathlessness. Different doses or routes of administration of opioids did not differ in effectiveness for breathlessness (SOE: low). Anxiolytics were not more effective than placebo for breathlessness (SOE: low). Evidence for other pharmacological interventions was limited. Opioids, bilevel ventilation, and activity/rehabilitation interventions had some harms compared to usual care. Conclusions. Some nonpharmacological interventions, including fans, acupressure/reflexology, multicomponent interventions, and bilevel ventilation, were effective for breathlessness in advanced cancer. Evidence did not support opioids or other pharmacological interventions within the limits of the identified studies. More research is needed on when the benefits of opioids may exceed harms for broader, longer term outcomes related to breathlessness in this population.

APA, Harvard, Vancouver, ISO, and other styles

5

Johnson, Corey, Colton James, Sarah Traughber, and Charles Walker. Postoperative Nausea and Vomiting Implications in Neostigmine versus Sugammadex. University of Tennessee Health Science Center, 2021. http://dx.doi.org/10.21007/con.dnp.2021.0005.

Full text

Abstract:

Purpose/Background: Postoperative nausea and vomiting (PONV) is a frequent complaint in the postoperative period, which can delay discharge, result in readmission, and increase cost for patients and facilities. Inducing paralysis is common in anesthesia, as is utilizing the drugs neostigmine and sugammadex as reversal agents for non-depolarizing neuromuscular blockers. Many studies are available that compare these two drugs to determine if neostigmine increases the risk of PONV over sugammadex. Sugammadex has a more favorable pharmacologic profile and may improve patient outcomes by reducing PONV. Methods: This review included screening a total of 39 studies and peer-reviewed articles that looked at patients undergoing general anesthesia who received non-depolarizing neuromuscular blockers requiring either neostigmine or sugammadex for reversal, along with their respective PONV rates. 8 articles were included, while 31 articles were removed based on our exclusion criteria. These were published between 2014 and 2020 exclusively. The key words used were “neostigmine”, “sugammadex”, “PONV”, along with combinations “paralytic reversal agents and PONV”. This search was performed on the scholarly database MEDLINE. The data items were PONV rates in neostigmine group, PONV rates in sugammadex group, incidence of postoperative analgesic consumption in neostigmine group, and incidence of postoperative analgesic consumption in sugammadex group. Results: Despite numerical differences being noted in the incidence of PONV with sugammadex over reversal with neostigmine, there did not appear to be any statistically significant data in the multiple peer-reviewed trials included in our review, for not one of the 8 studies concluded that there was a higher incidence of PONV in one drug or the other of an y clinical relevance. Although the side-effect profile tended to be better in the sugammadex group than neostigmine in areas other than PONV, there was not sufficient evidence to conclude that one drug was superior to the other in causing a direct reduction of PONV. Implications for Nursing Practice: There were variable but slight differences noted between both drug groups in PONV rates, but it remained that none of the studies determined it was statically significant or clinically conclusive. This review did, however, note other advantages to sugammadex over neostigmine, including its pharmacologic profile of more efficiently reversing non-depolarizing neuromuscular blocking drugs and its more favorable pharmacokinetics. This lack of statistically significant evidence found within these studies consequentially does not support pharmacologic decision-making of one drug in favor of the other for reducing PONV; therefore, PONV alone is not a sufficient rationale for a provider to justify using one reversal over another at the current time until further research proves otherwise.

APA, Harvard, Vancouver, ISO, and other styles

6

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text

Abstract:

Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.

APA, Harvard, Vancouver, ISO, and other styles

7

Saldanha, Ian J., Wangnan Cao, Justin M. Broyles, et al. Breast Reconstruction After Mastectomy: A Systematic Review and Meta-Analysis. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer245.

Full text

Abstract:

Objectives. This systematic review evaluates breast reconstruction options for women after mastectomy for breast cancer (or breast cancer prophylaxis). We addressed six Key Questions (KQs): (1) implant-based reconstruction (IBR) versus autologous reconstruction (AR), (2) timing of IBR and AR in relation to chemotherapy and radiation therapy, (3) comparisons of implant materials, (4) comparisons of anatomic planes for IBR, (5) use versus nonuse of human acellular dermal matrices (ADMs) during IBR, and (6) comparisons of AR flap types. Data sources and review methods. We searched Medline®, Embase®, Cochrane CENTRAL, CINAHL®, and ClinicalTrials.gov from inception to March 23, 2021, to identify comparative and single group studies. We extracted study data into the Systematic Review Data Repository Plus (SRDR+). We assessed the risk of bias and evaluated the strength of evidence (SoE) using standard methods. The protocol was registered in PROSPERO (registration number CRD42020193183). Results. We found 8 randomized controlled trials, 83 nonrandomized comparative studies, and 69 single group studies. Risk of bias was moderate to high for most studies. KQ1: Compared with IBR, AR is probably associated with clinically better patient satisfaction with breasts and sexual well-being but comparable general quality of life and psychosocial well-being (moderate SoE, all outcomes). AR probably poses a greater risk of deep vein thrombosis or pulmonary embolism (moderate SoE), but IBR probably poses a greater risk of reconstructive failure in the long term (1.5 to 4 years) (moderate SoE) and may pose a greater risk of breast seroma (low SoE). KQ 2: Conducting IBR either before or after radiation therapy may result in comparable physical well-being, psychosocial well-being, sexual well-being, and patient satisfaction with breasts (all low SoE), and probably results in comparable risks of implant failure/loss or need for explant surgery (moderate SoE). We found no evidence addressing timing of IBR or AR in relation to chemotherapy or timing of AR in relation to radiation therapy. KQ 3: Silicone and saline implants may result in clinically comparable patient satisfaction with breasts (low SoE). There is insufficient evidence regarding double lumen implants. KQ 4: Whether the implant is placed in the prepectoral or total submuscular plane may not be associated with risk of infections that are not explicitly implant related (low SoE). There is insufficient evidence addressing the comparisons between prepectoral and partial submuscular and between partial and total submuscular planes. KQ 5: The evidence is inconsistent regarding whether human ADM use during IBR impacts physical well-being, psychosocial well-being, or satisfaction with breasts. However, ADM use probably increases the risk of implant failure/loss or need for explant surgery (moderate SoE) and may increase the risk of infections not explicitly implant related (low SoE). Whether or not ADM is used probably is associated with comparable risks of seroma and unplanned repeat surgeries for revision (moderate SoE for both), and possibly necrosis (low SoE). KQ 6: AR with either transverse rectus abdominis (TRAM) or deep inferior epigastric perforator (DIEP) flaps may result in comparable patient satisfaction with breasts (low SoE), but TRAM flaps probably increase the risk of harms to the area of flap harvest (moderate SoE). AR with either DIEP or latissimus dorsi flaps may result in comparable patient satisfaction with breasts (low SoE), but there is insufficient evidence regarding thromboembolic events and no evidence regarding other surgical complications. Conclusion. Evidence regarding surgical breast reconstruction options is largely insufficient or of only low or moderate SoE. New high-quality research is needed, especially for timing of IBR and AR in relation to chemotherapy and radiation therapy, for comparisons of implant materials, and for comparisons of anatomic planes of implant placement.

APA, Harvard, Vancouver, ISO, and other styles

8

Zheng, Xing, Yingjun Cao, Fuzhong Xue, Aijun Wang, and Shucheng Si. The effects of Mediterranean-style diet on glycemic control, cardiovascular risk factors and weight loss in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.6.0096.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Garsa, Adam, Julie K. Jang, Sangita Baxi, et al. Radiation Therapy for Brain Metasases. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer242.

Full text

Abstract:

Objective. This evidence report synthesizes the available evidence on radiation therapy for brain metastases. Data sources. We searched PubMed®, Embase®, Web of Science, Scopus, CINAHL®, clinicaltrials.gov, and published guidelines in July 2020; assessed independently submitted data; consulted with experts; and contacted authors. Review methods. The protocol was informed by Key Informants. The systematic review was supported by a Technical Expert Panel and is registered in PROSPERO (CRD42020168260). Two reviewers independently screened citations; data were abstracted by one reviewer and checked by an experienced reviewer. We included randomized controlled trials (RCTs) and large observational studies (for safety assessments), evaluating whole brain radiation therapy (WBRT) and stereotactic radiosurgery (SRS) alone or in combination, as initial or postoperative treatment, with or without systemic therapy for adults with brain metastases due to non-small cell lung cancer, breast cancer, or melanoma. Results. In total, 97 studies, reported in 190 publications, were identified, but the number of analyses was limited due to different intervention and comparator combinations as well as insufficient reporting of outcome data. Risk of bias varied; 25 trials were terminated early, predominantly due to poor accrual. Most studies evaluated WBRT, alone or in combination with SRS, as initial treatment; 10 RCTs reported on post-surgical interventions. The combination treatment SRS plus WBRT compared to SRS alone or WBRT alone showed no statistically significant difference in overall survival (hazard ratio [HR], 1.09; confidence interval [CI], 0.69 to 1.73; 4 RCTs; low strength of evidence [SoE]) or death due to brain metastases (relative risk [RR], 0.93; CI, 0.48 to 1.81; 3 RCTs; low SoE). Radiation therapy after surgery did not improve overall survival compared with surgery alone (HR, 0.98; CI, 0.76 to 1.26; 5 RCTs; moderate SoE). Data for quality of life, functional status, and cognitive effects were insufficient to determine effects of WBRT, SRS, or post-surgical interventions. We did not find systematic differences across interventions in serious adverse events radiation necrosis, fatigue, or seizures (all low or moderate SoE). WBRT plus systemic therapy (RR, 1.44; CI, 1.03 to 2.00; 14 studies; moderate SoE) was associated with increased risks for vomiting compared to WBRT alone. Conclusion. Despite the substantial research literature on radiation therapy, comparative effectiveness information is limited. There is a need for more data on patient-relevant outcomes such as quality of life, functional status, and cognitive effects.

APA, Harvard, Vancouver, ISO, and other styles

10

A psychiatric technician dies from a patient assault at a forensic psychiatric facility. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2012. http://dx.doi.org/10.26616/nioshsface10ca009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!